IGFBP3 and Stroke: The reduction of plasma IGFBP-3 in stroke patients could be a positive response to increase the amount of bioavailable IGF-1 in the circulation, whereas the low plasma cGP suggests a reduction of bioavailable IGF-1 in circulation during the onset of stroke [36].